Showing 2171-2180 of 5957 results for "".
- FDA Clears First Daily Disposable Silicone Hydrogel Contact Lens Coated with Modified Formula of Tangible Hydra-PEGhttps://modernod.com/news/fda-clears-first-daily-disposable-silicone-hydrogel-contact-lens-coated-with-modified-formula-of-tangible-hydra-peg/2479611/Tangible Science announced that the FDA has cleared the first daily disposable silicone hydrogel contact lens coated with a modified formula of Tangible Hydra-PEG. Tangible Hydra-PEG is an innovative coating applied to custom contact lenses to improve lens wettability and deposit resistanc
- The Number of Optometric Practices Offering neurolens Contoured Prism Lenses More Than Quadrupled in 2018https://modernod.com/news/the-number-of-optometric-practices-offering-neurolens-contoured-prism-lenses-more-than-quadrupled-in-2018/2479617/Costa Mesa, California-based neurolens announced that adoption of their prescription lenses has grown among US optometric (OD) practices and by year end, 31 states will carry the company’s neurolenses and the neurolens measurement device. neurolenses are the first and only prescripti
- AcuFocus Receives IDE Approval from the FDA to Begin Clinical Study of the IC-8 Lenshttps://modernod.com/news/acufocus-receives-ide-approval-from-the-fda-to-begin-clinical-study-of-the-ic-8-lens/2479646/AcuFocus announced that it has received approval for an investigational device exemption (IDE) from the FDA to conduct a pivotal study of the company’s IC-8 small aperture IOL for patients with cataracts. The AcuFocus IC-8 IOL is a clear monofocal lens with an embedded mini-ring or pinhole
- FDA Revamping Clearance Procedures for Medical Deviceshttps://modernod.com/news/fda-revamping-clearance-procedures-for-medical-devices/2479649/The FDA is significantly revamping the way it clears most medical devices for U.S. marketing, planning to rely far less on comparisons with much older products already on the market, according to a
- Verily, Alcon, Halt Project to Create a Glucose-Measuring Contact Lens; Other Eye-Monitoring Projects Continuehttps://modernod.com/news/verily-alcon-halt-work-on-glucose-sensing-smart-contact-lens/2479656/Google’s life sciences company Verily and Alcon have decided to halt their work on a smart contact lens to measure glucose levels in users with diabetes. In a blog post, Verily chief technical o
- RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disordershttps://modernod.com/news/retipharma-secures-funding-to-develop-treatments-of-degenerative-eye-disorders/2479680/RetiPharma has announced that it has secured funding from the Novo Nordisk Foundation’s BioInnovation Institute (BII). The funding will be used to prepare its lead drug RP001 for a clinical proof-of-concept study in patients with retinal detachment as well as to in source additional compounds usi
- Carl Zeiss Meditec to Acquire IanTECH, Maker of the miLOOP Device for Cataract Surgeryhttps://modernod.com/news/carl-zeiss-meditec-to-acquire-iantech-maker-of-the-miloop-device-for-cataract-surgery/2479758/Carl Zeiss Meditec announced it has entered into an agreement to acquire IanTECH, the manufacturer of the miLOOP device for cataract surgery. miLOOP is a microinterventional device designed to deliver energy-free endocapsular lens fragmentation independent of phaco energy. Terms of the d
- Altris.AI Partners With Huvitz for Development of AI-Based Retinal Detectionhttps://modernod.com/news/altris-ai-the-new-era-of-retinal-diagnosis-is-coming/2479785/Artificial intelligence company Altris.Al announced it has signed an agreement with South Korean ophthalmic and optical medical equipment manufacturer Huvitz Co. aimed at the development of customized deep learning solutions for retinal diseases detection. Terms of the deal were not disclo
- Department of Defense Grant for Clinical Trial of Stem Cell Therapy for Eye Injurieshttps://modernod.com/news/department-of-defense-grant-for-clinical-trial-of-stem-cell-therapy-for-eye-injuries/2479809/Researchers at the University of Illinois at Chicago have received a 4-year, $5.25 million grant from the U.S. Department of Defense to lead a multisite clinical trial to test the efficacy of a stem cell-based treatment for eye injuries. The treatment uses mesenchymal stem cells—cells that
- The Vision Council Conducts Study on Contact Lens Subscription Serviceshttps://modernod.com/news/the-vision-council-conducts-study-on-contact-lens-subscription-services/2479830/The Vision Council’s market research team has developed an industry first look at the new and emerging contact lens subscription services. This study aims to examine the potential impact on the contact lens and optical retail industries. “We have recently seen several new contact lens subs